Bone Pathology Flashcards
Osteomyelitis
Definition: inflammatory lesion
Etiology: bacterial infection (septicemia)
Staphylococcus aureus
Young child, pain in a long bone
Metaphysis (adjacent to the epiphyseal plate)
Risk: sickle cell disease, complication of compound fractures
Localized bone pain, swelling
Radiological changes, blood cultures are positive, open biopsy
Treatment antibiotics
Pathogenesis of Osteomyelitis
- Infection > Bacteremia
- Acute inflammation in metaphysis of long bone
- Necrosis of bone forming the sequestrum
- Reactive new bone: the involucrum (woven bone)
- Untreated > sinuses form, draining pus via cloacae
General Steps of Bone Infection
- Normal bone with capillaries close to epiphyseal plate (most affected area)
- Infection occurs
- Bacteria is invading and growing; if goes untreated, then it spreads
- Reaction of woven bone/ spread and invasion of bacteria
Involucrum
Subperiostial shell of viable new bone
Cloaca
Hole formed in the bone during the formation of a draining sinus
Sequestrum
Any tissue that has been sequestered
Example: a piece of dead bone that has become separated during the process of necrosis from the sound bone
Metastasis into the Bone
- Colonization of tumor in the tissue (primary)
- Angiogenesis occurs (production of vessels) to feed the tumor
- Invasion of primary tumor cells into the vessels and usually these metastasize
Once cells go into vessels and reach the bone, similar process like osteomyelitis where the cells invade the bone; appendicular skeleton is most frequently involved
Cancer Activation of Osteoclasts vs. Osteoblasts
Cancer cells activate osteoclasts cause osteolytic metastases
Cancer cells activate osteoblasts cause osteoblastic lesions
Myeloma cells create exclusively osteolytic lesions in bone
Kidney, lung, GI and malignant melanoma = lytic bone lesions
Prostate = Wnt proteins = osteoblastic bone formation
Most metastatic disease are mixed lesions
Vicious Cycle of Cancer Cells & Bone Cells
Cancer activates PTHrP to activate osteoblasts then RANKL/RANK to activate osteoclasts to cause demineralization and GFs to increase the cancer cells = cycle continues
OPG is an Ab that interferes with RANK ligand to eliminate activation of osteoclasts and then is prevents or decreases metastatic disease; non specific to tumor cells but can happen in other cases as well
Osteoid Osteoma
Small and painful lesion
Osseous tissue (nidus) surrounded by reactive bone formation
5-25 years old
Cortex of diaphysis of tubular bones lower extremity
Spherical, hyperemic, 1 cm diam., easily enucleated
Micro: thin, irregular, trabeculae within a cellular granulation tissue containing osteoblasts and osteoclasts, more mature in the center, often partially calcified
Clinical presentation: pain, nocturnal, exacerbated by the intake of alcohol and relieved by aspirin (prostaglandin)
Treatment: surgical excision
Osteochondroma
Osteochondroma with a thickened hyaline cartilage cap which matures via endochondral calcification to bony trabeculae surrounded by fat and hematopoietic marrow
Osteosarcoma
Highly malignant
Adolescents 10-20 years old
2:1 male to female
2/3 mutations in the retinoblastoma (Rb) gene; p53.
Tall persons, often arises near the knee, proximal humerus second most common site
75% arise adjacent to the knee or shoulder
Woven bone in periosteum; reactive bone makes a triangle around to prevent invasion of tumor
Osteosarcoma Hallmarks
Bone destruction and formation (neoplastic bone)
Codman triangle incomplete rim of reactive bone produced by periosteum
Gross is variable
Malignant cells with osteoblastic differentiation producing woven bone.
+ for alkaline phosphatase and osteonectin
Spreads through the bloodstream to the lungs
Osteosarcoma Clinical Features and Tx
Mild or intermittent pain
Swollen and tender
Adjacent joint becomes functionally limited
Serum alkaline phosphatase increased (*)
Treatment amputation or disarticulation + chemotherapy
Ewing Sarcoma
Primary small round cell tumor 6-10% of primary malignant bone tumors Ewing sarcoma / PNET Youngest age at presentation 10-15 y/o boys, whites t(11,22) translocation causes (EWS-FLI1) fusion = dominant oncogene